CuraTeQ Biologics s.r.o. receives positive opinion for biosimilar Dazublys from EMA
Used for treatment of HER2-positive metastatic and early breast cancers
CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorisation of Dazublys (150 mg powder for concentrate for solution for infusion), its trastuzumab biosimilar, for the treatment of HER2-positive metastatic and early breast cancers.
Trastuzumab specifically binds and inhibits the human epidermal growth factor receptor 2 (HER2) protein, which is over-expressed on certain types of solid cancers such as breast and gastric cancer. By binding to the extracellular domain of HER2, trastuzumab disrupts its ability to signal, leading to cell cycle arrest, reduced tumor growth, and potentially immune system activation to destroy cancer cells.
Aurobindo Pharma's Vice Chairman and Managing Director Mr. Nithyananda Reddy said, "The CHMP's positive opinion of a third biosimilar from our portfolio in a five-month time period underscores our extensive efforts in building biosimilars as one of the core businesses at Aurobindo. By 2030, we are committed to launching at least 10 biosimilars across oncology and immunology therapy segments, furthering our mission to serve patients with high-quality, cost-effective therapies."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
14 hours ago
- New Indian Express
Recording of statement delayed as MSC Elsa 3 crew test Covid positive
KOCHI: Though police have registered a case in connection with the sinking of the Liberian cargo ship MSC Elsa 3, they are yet to record statements from the crew as most of them have tested positive for Covid-19. The crew members are under quarantine at a hotel in Kochi. According to police, the crew underwent medical tests recently, following which most of them were found to be Covid-positive. 'We are in touch with the shipping company, which has informed us that most of the crew members are currently infected. We will wait for their health to improve before recording their statements. Meanwhile, we have sought details from the company regarding the wreckage and the cargo containers that fell into the sea.
Hans India
3 days ago
- Hans India
52-year-old woman dies of Covid-19 in Indore
Bhopal: Amid concern over rising cases of COVID-19 in Madhya Pradesh, a 52-year-old woman died of the virus during treatment at a private hospital in Indore. The woman, a resident of Ratlam, around 150 km from Indore, was admitted to Manorma Raje T B (MRTB) hospital in Indore with complaints of respiratory distress on June 8. Meanwhile, a COVID test was also conducted. Two days later, on Wednesday, medical reports revealed that she was COVID-positive. Subsequently, she was shifted to the isolation ward. She died on June 11, a senior doctor at MRTB hospital said on Thursday. The hospital administration also confirmed that the patient was suffering from multiple diseases, including tuberculosis and hypertension, due to which her health condition continued to deteriorate. This marks the third death of COVID-affected patients in the past two weeks in Madhya Pradesh, and more importantly, all of them were women. Two of them died at Indore's MRTB hospital, including the fresh fatality on Wednesday, while one passed away at Aurobindo Hospital in the city. Earlier, a 44-year-old woman from Khargone, who gave birth at MTH Hospital, tragically died at MRTB Hospital from intrapartum seizures after testing positive for COVID-19. She had delivered a healthy baby boy weighing 3.1 kg on May 28, but succumbed just eight days later. Previously, a 74-year-old woman from Indore, who was also Covid-19 positive, passed away while undergoing treatment for renal failure at Aurobindo Hospital. Indore reported 12 new COVID-19 patients on Wednesday, taking the total cases to 82 this year across Madhya Pradesh. Active cases stand at 51, according to official information. Notably, India has 7,154 active COVID-19 cases. Three people died while 33 fresh cases have been reported in the past 24 hours. Health advisories are being circulated, especially for the elderly and immunocompromised patients. Additionally, the centre has urged citizens to remain cautious and adhere to preventive measures while also ramping up testing.
Time of India
5 days ago
- Time of India
43 more XFG cases takes total tally in state to 49
Kolkata: The new Covid-19 variant, XFG, was found in 43 more Covid-positive samples in Bengal during whole genome sequencing. This brings the total number of XFG variant cases in Bengal to 49. While the number of samples being sequenced is still not high enough, doctors said this strain could be causing the current spike in the state as well as in other parts of the country. Health officials said that XFG belongs to the Omicron family of Covid-19, and despite its high transmissibility, this variant is known to cause only mild infection in most cases. "With XFG isolated in most positive samples, this variant is emerging as the dominant variant in circulation during this spike. But there is nothing to worry about as this variant is causing only mild infection," said a health official. By Tuesday, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) detected 206 XFG variant cases across the country. In Maharashtra, 89 cases of this new variant were found, while Tamil Nadu and Kerala followed with 16 and 15 cases, respectively. Yogiraj Ray, head of the infectious diseases department at IPGMER, said,"While this variant can emerge as the dominant variant in circulation, there is nothing to worry about as it is an offshoot of Omicron. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Here's The Price for a 1-Day Walk-in Shower In 2025 Homebuddy Learn More Undo In fact, two post-transplant patients – kidney and liver – who tested positive for Covid-19 did not get severe infection." "Covid-19 is endemic and will stay in the community now. XFG is known to be immune evasive. A variant with high transmissibility and low mortality is likely to spike rapidly but subside fast. Since the current spike is causing mostly mild infection, we should not worry. But genomic sequencing should be carried out on a regular basis so that any aberrant mutation can be detected on time for better preparedness and also to mitigate unnecessary panic," said Sumon Poddar, associate professor of paediatrics at the Institute of Child Health Kolkata, who is also attached to the microbiology lab of the institute.
